Healthcare
Frontline Topics
- Digital therapeutics
- Realization of treatment through apps, not pharmaceuticals or medical devices. Digital, not just pharmaceutical aids, eliminates the boundary between unwellness and treatment.
- Value-based healthcare
- A shift to patient outcome-centered metrics in healthcare services involving the pharmaceutical industry, medical institutions, academia, and insurers.
Issues
- Patient-centricity
- How to achieve service design and organizational changes that focus on patients, not just healthcare professionals, including related services.
- Personal health records
- How can PHRs, which are being implemented on the My Number board, be linked to the convenience and value provided in cooperation with private companies in order to realize patient-centered healthcare.
- Medical AI
- As practical applications in diagnostic imaging continue to advance, what is the best combination of doctors and AI to maximize patient outcomes while addressing ethical concerns.
- Digital/AI drug discovery process
- How AI can be used in identifying drug candidate molecules and disease targets, using real-world data, and remote drug discovery processes.
- Digital supply chain
- How to provide quality assurance and traceability from End to End to patients.(pharmaceutical company -> drug wholesaler -> medical institution)
Cases
- Strategy - Ecosystem -
- Creating a vision for future healthcare ecosystem
We drew up a future vision for the healthcare industry and examined what position the client should aim for, then promoted M&A and alliance strategies to reinforce their lacking assets.
- Strategy - Rebranding -
- Designing patient-centric channels
We redesigned the client's customer journeys including patients and doctors, and established a company-wide target state. On that basis, we identified collaboration solutions, and drafted implementation plans, etc.
- Digital - Data Leverage -
- Starting up a medical data-leveraged business
We promoted the client's medical data platform business from the concept development to the launch. Furthermore, we developed the business model, researched for user needs, and implemented the IT system infrastructure.
- Digital - Data Leverage -
- Developing strategies for utilizing real world data
We identified needs for utilizing real world data by focusing on pharmaceutical companies, and defined a business roadmap and plan.
- Strategy - New Product -
- Developing a strategy to launch a new drug
Towards client's new drug launch, we developed a strategy to significantly reduce the preparation lead time and gain marke dominance. Then, we desgined digital technology-enabled information provision and logistics.
- Operation - BPR -
- Re-engineering business processes in the pharmacovigilance department
To establish a structure to respond to upcoming adverse event reporting, we identified issues solutions through organization diagnosis. We also standardized the processes, developed captive human resources, and strengthened their organizations.
